The Industrialization of Clinical Research

Richard A. Rettig

ResearchPosted on rand.org 2000Published in: Health Affairs, v. 19, no. 2, Mar./Apr. 2000, p. 129-146

Recent controversies over the protection of human subjects, payment of physicians for recruiting patients to clinical trials, Food and Drug Administration (FDA) removal of approved drugs from the market, and reporting of results of clinical trials have highlighted important facets of clinical research. Less visible has been the industrialization of clinical research, and especially of clinical trials, that is, its emergence as a line of business of substantial magnitude and rapid growth. The growth of drug-industry outsourcing of clinical trials and the concomitant rise of a contract research industry are described in this paper, which argues for greater transparency in the conduct of both publicly and privately sponsored clinical trials.

Read More

Topics

Document Details

  • Copyright: Project HOPE
  • Publisher: Project HOPE
  • Availability: Non-RAND
  • Year: 2000
  • Pages: 18
  • DOI: https://doi.org/10.7249/pubs
  • Document Number: EP-200003-02

This publication is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.